Utilizing the Patient Health Questionnaire (PHQ-2) as a depression screening tool for patients with hidradenitis suppurativa.
作者信息
Ghanshani Raveena, Moon Chelsea, Joshi Aditya, Park Sarah E, Shi Vivian Y, Hsiao Jennifer L, Lee Katrina H
机构信息
Keck School of Medicine of USC, University of Southern California, Los Angeles, California.
Creighton University School of Medicine, Phoenix, Arizona.
出版信息
Int J Womens Dermatol. 2025 Aug 20;11(3):e223. doi: 10.1097/JW9.0000000000000223. eCollection 2025 Oct.
Abstract
摘要
相似文献
1
Utilizing the Patient Health Questionnaire (PHQ-2) as a depression screening tool for patients with hidradenitis suppurativa.
Int J Womens Dermatol. 2025 Aug 20;11(3):e223. doi: 10.1097/JW9.0000000000000223. eCollection 2025 Oct.
2
Psychometric validation and interpretation thresholds of the Hidradenitis Suppurativa Quality of Life (HiSQOL©) questionnaire using pooled data from the phase III BE HEARD I & II trials of bimekizumab in hidradenitis suppurativa.
Br J Dermatol. 2025 Jun 20;193(1):93-104. doi: 10.1093/bjd/ljaf067.
3
Validation of the real-world application of the Hidradenitis Suppurativa Quality of Life (HiSQOL) score to adults with hidradenitis suppurativa.
Br J Dermatol. 2025 Jan 24;192(2):261-268. doi: 10.1093/bjd/ljae367.
4
Identifying and Evaluating Mobile and Web Apps for Patients to Manage Hidradenitis Suppurativa: Systematic Search in App Stores and Content Analysis.
JMIR Mhealth Uhealth. 2025 Aug 29;13:e69030. doi: 10.2196/69030.
5
Bimekizumab Impact on Patient-Reported Outcomes in Patients with Moderate to Severe Hidradenitis Suppurativa: Pooled 48-Week Results from BE HEARD I&II.
Dermatol Ther (Heidelb). 2025 Jul 13. doi: 10.1007/s13555-025-01465-4.
6
Bimekizumab for the treatment of hidradenitis suppurativa.
Immunotherapy. 2024;16(16-17):1005-1013. doi: 10.1080/1750743X.2024.2401308. Epub 2024 Sep 19.
7
Evaluating the Internet as a Source of Information for Patients With Hidradenitis Suppurativa: A Review of Websites' Content, Insights Into Engagement, and Access.
Dermatol Surg. 2024 Dec 1;50(12):1167-1174. doi: 10.1097/DSS.0000000000004323. Epub 2024 Jul 10.
8
The association between hidradenitis suppurativa and psychiatric disease: a systematic review and meta-analysis.
Br J Dermatol. 2025 Jul 17;193(2):212-220. doi: 10.1093/bjd/ljaf151.
9
Prevalence of Hidradenitis Suppurativa in Brussels, Belgium: Validation of a Screening Questionnaire.
Dermatology. 2025 Jul 7:1-5. doi: 10.1159/000539477.
10
Efficacy and safety of radiofrequency in the treatment of hidradenitis suppurativa; a systematic review.
Lasers Med Sci. 2024 May 25;39(1):139. doi: 10.1007/s10103-024-04077-0.
本文引用的文献
1
Psoriasis Involving Special Areas is Associated with Worse Quality of Life, Depression, and Limitations in the Ability to Participate in Social Roles and Activities.
J Psoriasis Psoriatic Arthritis. 2023 Jul;8(3):100-106. doi: 10.1177/24755303231160683. Epub 2023 Mar 17.
2
Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations.
J Am Acad Dermatol. 2022 May;86(5):1092-1101. doi: 10.1016/j.jaad.2021.01.059. Epub 2021 Jan 23.
3
Depression and psychological distress in US adults with atopic dermatitis.
Ann Allergy Asthma Immunol. 2019 Aug;123(2):179-185. doi: 10.1016/j.anai.2019.06.002. Epub 2019 Jun 13.
4
Depression in hidradenitis suppurativa.
Br J Dermatol. 2019 Nov;181(5):1087-1088. doi: 10.1111/bjd.18132. Epub 2019 Aug 6.
5
Incidence of hidradenitis suppurativa in the United States: A sex- and age-adjusted population analysis.
J Am Acad Dermatol. 2017 Jul;77(1):118-122. doi: 10.1016/j.jaad.2017.02.005. Epub 2017 Mar 9.
Zotero 插件